Ivermectin Squares Off in a New War on Cancer

(Source:  RESCUE with Michael Capuzzo)

Medical pioneers are putting their Covid treatment expertise to new uses. For two cancer patients, that meant ‘complete clinical response.’

With this article, I begin what I hope will be a series of reports on the use of inexpensive generic drugs for the treatment of cancer. In one of the few good things to come out of the SARS-CoV-2 pandemic, a growing number of physicians who pioneered effective early treatments for Covid-19 is now attempting to learn if safe, off-patent drugs can also work for cancer. So far, results are promising for drugs like ivermectin, mebendazole, and metformin, and supplements like melatonin.

I will write about this emerging movement from the the conference in Phoenix of the Front Line Covid-19 Critical Care Alliance this weekend, where cancer care will be highlighted. (I’m on a panel on censorship Saturday; join me there or watch afterward online.) Here now is the story of one patient and what it may mean for others.